| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/20/2003 | CA2810339A1 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
| 02/20/2003 | CA2459071A1 Use of inhibitors of heparin-binding epidermal growth factor or inhibitors of its receptors for the preparation of drugs useful for treating myeloma |
| 02/20/2003 | CA2457322A1 Process for the maturation of dentritic cells and a vaccine |
| 02/20/2003 | CA2456964A1 Melanin-concentrating hormone antagonists |
| 02/20/2003 | CA2456942A1 Compositions and methods for modulation of darpp-32 phosphorylation |
| 02/20/2003 | CA2456939A1 Carbonic anhydrase inhibitors |
| 02/20/2003 | CA2456909A1 Methods for the treatment and prognosis of leukemia and other cancer types |
| 02/20/2003 | CA2456881A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 02/20/2003 | CA2456802A1 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder |
| 02/20/2003 | CA2456744A1 Adenosine a3 receptor agonists |
| 02/20/2003 | CA2456723A1 Inhibitors of her3 activity |
| 02/20/2003 | CA2456607A1 Uses of mammalian cytokine; related reagents |
| 02/20/2003 | CA2456553A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 02/20/2003 | CA2456550A1 Tumour inhibiting cerium compounds |
| 02/20/2003 | CA2456523A1 C-2' methylated derivatives of paclitaxel for use as antitumour agents |
| 02/20/2003 | CA2456369A1 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | CA2456328A1 Complexes of a short cpg-containing oligonucleotide bound to the surface of a solid phase microcarrier and methods for use thereof |
| 02/20/2003 | CA2456291A1 Hydroxamic acid derivatives |
| 02/20/2003 | CA2456288A1 Fatty acid compounds, preparation and uses thereof |
| 02/20/2003 | CA2456287A1 Anti-idiotypic antibodies of hla class i molecules and the use thereof in the preparation of compositions that are designed to inhibit vascular activation |
| 02/20/2003 | CA2456255A1 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof |
| 02/20/2003 | CA2456236A1 Methods of screening based on the egf receptor crystal structure |
| 02/20/2003 | CA2456175A1 Benzoquinone ansamycins |
| 02/20/2003 | CA2456144A1 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | CA2456034A1 Sustained-release medicines |
| 02/20/2003 | CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| 02/20/2003 | CA2455759A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 02/20/2003 | CA2455631A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 02/20/2003 | CA2454768A1 Molecule |
| 02/20/2003 | CA2454648A1 Irinotecan for treatment of cancer |
| 02/20/2003 | CA2454643A1 Methods for the treatment of cancer with irinotecan based on cyp3a5 |
| 02/20/2003 | CA2454640A1 Methods for treatment of cancer using irinotecan based on ugt1a1 |
| 02/20/2003 | CA2454637A1 Use of irinotecan for improved treatment of cancer based on mdr1 |
| 02/20/2003 | CA2454627A1 Methods for improved treatment of cancer with irinotecan based on mrp1 |
| 02/20/2003 | CA2454519A1 Hprp4s as modifiers of the p53 pathway and methods of use |
| 02/20/2003 | CA2454514A1 Sphks as modifiers of the p53 pathway and methods of use |
| 02/20/2003 | CA2454417A1 Novel benzo-fused heterocycles as endothelin antagonists |
| 02/20/2003 | CA2454081A1 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 02/20/2003 | CA2453995A1 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | CA2453248A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | CA2453245A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 02/20/2003 | CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | CA2450777A1 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
| 02/20/2003 | CA2428822A1 Modulators of p-selectin glycoprotein ligand 1 |
| 02/19/2003 | WO2002016574A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 02/19/2003 | EP1284288A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 02/19/2003 | EP1284272A1 Estra-1,3,5(10)-triene derivatives |
| 02/19/2003 | EP1284265A1 Benzothiophene derivatives and medicinal use thereof |
| 02/19/2003 | EP1284144A1 Anti-tumor vaccines |
| 02/19/2003 | EP1283905A2 Diagnosis of diseases associated with the cell cycle |
| 02/19/2003 | EP1283903A1 Drug screening systems and assays |
| 02/19/2003 | EP1283894A1 Use of baculovirus vectors in gene therapy |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283885A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/19/2003 | EP1283884A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 02/19/2003 | EP1283874A2 Novel deoxynucleoside kinase enzyme variants |
| 02/19/2003 | EP1283871A2 Production of dendritic cells from bone-marrow stem cells |
| 02/19/2003 | EP1283850A2 Thrombospondin type 1 repeat polypeptides |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283842A1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation |
| 02/19/2003 | EP1283836A2 Neuroprotective and anti-proliferative compounds |
| 02/19/2003 | EP1283835A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 02/19/2003 | EP1283828A1 Novel polymorph v of torasemide |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP1283823A1 Novel mmp-2/mmp-9 inhibitors |
| 02/19/2003 | EP1283726A2 Dendritic cells loaded with toxic substances |
| 02/19/2003 | EP1283723A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/19/2003 | EP1283722A1 Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma |
| 02/19/2003 | EP1283721A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/19/2003 | EP1283715A1 Modulaton of alpha-6 integrin-mediated responses |
| 02/19/2003 | EP1283712A1 Combination chemotherapy |
| 02/19/2003 | EP1283707A1 Polymerizable compositions and methods of use |
| 02/19/2003 | EP1283672A1 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin" |
| 02/19/2003 | EP1133491B1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same |
| 02/19/2003 | EP1131327B1 Prostaglandin conjugates for treating or preventing bone diseases |
| 02/19/2003 | EP1027345B1 Synthetic methods for polyphenols |
| 02/19/2003 | EP0931083B1 Process for producing ecteinascidin compounds |
| 02/19/2003 | EP0863752B1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
| 02/19/2003 | EP0777485B1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 02/19/2003 | EP0690867B1 Taxanes having furyl or thienyl substituted side-chain |
| 02/19/2003 | EP0687260B1 Process for the preparation of 9-desoxotaxanes |
| 02/19/2003 | CN1398297A Recombinant flaviviruses and methods of use thereof |
| 02/19/2003 | CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives |
| 02/19/2003 | CN1398264A 吲哚－3－基衍生物 Indol-3-yl derivative |
| 02/19/2003 | CN1398260A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 02/19/2003 | CN1398247A Colchinol derivatives as vascular damaging agents |
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/19/2003 | CN1398187A Method and compsns. for treating liver cell cancer |
| 02/19/2003 | CN1398185A Method to potentiate therapueutic efficiency of taxane and derivatives thereof |
| 02/19/2003 | CN1398183A Medicament contg. platinum complex compounds and use thereof |
| 02/19/2003 | CN1397567A Spiruline polyose, its extraction process and it medical application in increasing white cells and treating cancer |
| 02/19/2003 | CN1397566A Atractylodes polyose with antineoplastic and immunoregualting functions and its preparing process and application |
| 02/19/2003 | CN1397565A Inokopolyose derivative and its preparing and application |
| 02/19/2003 | CN1397327A Liquid medicine for treating dermatopathy |
| 02/19/2003 | CN1397284A Embedded nusk and its preparing process |
| 02/19/2003 | CN1397281A Hydroxycamptothecin dropping pill and its preparing process |
| 02/19/2003 | CN1397280A Freeze dried hydroxycamptothecin powder injection and its preparing process |
| 02/19/2003 | CN1397279A Hydroxycamptothecin tablet and its preparing process |
| 02/19/2003 | CN1397183A Glaucescent fissitigma tea |